BerGenBio ASA (BGBIO.OL)
NOK 8.72
(-2.83%)
NOK 8.72
(-2.83%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 354 Thousand | 389 Thousand | 774 Thousand | 601 Thousand | 8.9 Million | 2.33 Million |
| Cost of Revenue | - | - | - | 89.46 Million | 65.25 Million | 66.49 Million |
| Gross Profit | 354 Thousand | 389 Thousand | 774 Thousand | -88.86 Million | -56.35 Million | -64.15 Million |
| Operating Expenses | 192.17 Million | 306.02 Million | 315.23 Million | 261.69 Million | 213.27 Million | 196.87 Million |
| Selling, General and Administrative Expenses | 84.38 Million | 105.05 Million | 12.74 Million | 21.79 Million | 21.22 Million | 10.29 Million |
| Research and Development Expenses | 151.4 Million | 8.34 Million | 12.74 Million | 21.79 Million | 21.22 Million | 10.29 Million |
| Other Expenses | - | 297.68 Million | 289.74 Million | 218.1 Million | 170.82 Million | 186.58 Million |
| Cost and Expenses | 192.17 Million | 306.02 Million | 315.23 Million | 261.69 Million | 213.27 Million | 196.87 Million |
| Operating Income | -191.81 Million | -305.63 Million | -314.46 Million | -261.09 Million | -204.37 Million | -194.53 Million |
| Interest Expense | 578 Thousand | 321 Thousand | 53 Thousand | 32 Thousand | 109 Thousand | 47 Thousand |
| Income Tax Expense | - | -3.51 Million | 53 Thousand | 32 Thousand | 109 Thousand | 2.83 Million |
| Earnings before Tax | -190.4 Million | -302.12 Million | -309.36 Million | -257.02 Million | -199.27 Million | -191.74 Million |
| Net Income | -190.4 Million | -298.6 Million | -309.41 Million | -257.06 Million | -199.38 Million | -191.74 Million |
| Earnings Per Share Basic | -13.30 | -38.65 | -40.36 | -39.37 | -38.76 | -40.60 |
| Earnings Per Share Diluted | -13.30 | -38.65 | -40.36 | -39.37 | -38.76 | -40.60 |
| Weighted Average Shares Outstanding | 14.31 Million | 7.72 Million | 7.66 Million | 6.53 Million | 5.14 Million | 4.72 Million |
| Weighted Average Shares Outstanding (Diluted) | 14.31 Million | 7.72 Million | 7.66 Million | 6.53 Million | 5.14 Million | 4.72 Million |
| Gross Margin | 1.00 | 1.00 | 1.00 | -147.87 | -6.33 | -27.48 |
| EBIT Margin | -541.81 | -773.57 | -397.93 | -426.41 | -22.29 | -82.01 |
| Profit Margin | -537.86 | -767.63 | -399.76 | -427.72 | -22.40 | -82.12 |
| EBITDA | -191.8 Million | -300.91 Million | -307.99 Million | -260.92 Million | -198.38 Million | -191.54 Million |
| Earnings Before Tax Margin | -541.86 | -785.69 | -406.28 | -434.43 | -22.96 | -83.31 |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Revenue | - | 167 Thousand | 354 Thousand | 354 Thousand | - | - |
| Cost of Revenue | 105 Thousand | 17.29 Million | 84.27 Million | 16.79 Million | 109 Thousand | 7000.00 |
| Gross Profit | -105 Thousand | -17.13 Million | -83.92 Million | -16.44 Million | -109 Thousand | -7000.00 |
| Operating Expenses | 51.76 Million | 23.74 Million | 192.17 Million | 43.89 Million | 28.09 Million | 47.76 Million |
| Selling, General and Administrative Expenses | 19.24 Million | 318 Thousand | - | 1.6 Million | 18.83 Million | 26.02 Million |
| Research and Development Expenses | 32.52 Million | 23.42 Million | - | 29.35 Million | 9.76 Million | 1.69 Million |
| Other Expenses | 38.15 Million | - | - | - | - | - |
| Cost and Expenses | 51.86 Million | 41.03 Million | 192.17 Million | 43.89 Million | 28.09 Million | 47.76 Million |
| Operating Income | -51.86 Million | -40.87 Million | -191.81 Million | -43.54 Million | -28.09 Million | -47.76 Million |
| Interest Expense | 1.35 Million | 707 Thousand | 578 Thousand | -9.11 Million | 3.91 Million | 3.08 Million |
| Income Tax Expense | - | 61.72 Thousand | 1.99 Million | -7.2 Million | 4.07 Million | 2 Million |
| Earnings before Tax | -49.72 Million | -36.11 Million | -190.4 Million | -41.63 Million | -27.93 Million | -48.83 Million |
| Net Income | -49.72 Million | -36.11 Million | -190.4 Million | -41.63 Million | -27.93 Million | -48.83 Million |
| Earnings Per Share Basic | -1.85 | -1.34 | - | -1.55 | -3.16 | -14.51 |
| Earnings Per Share Diluted | -1.85 | -1.34 | - | -1.55 | -3.16 | -14.51 |
| Weighted Average Shares Outstanding | 26.88 Million | 26.88 Million | 14.31 Million | 26.88 Million | 8.83 Million | 3.36 Million |
| Weighted Average Shares Outstanding (Diluted) | 26.88 Million | 26.88 Million | 14.31 Million | 26.88 Million | 8.83 Million | 3.36 Million |
| Gross Margin | - | -102.57 | -237.07 | -46.44 | - | - |
| EBIT Margin | - | -244.10 | - | -143.06 | - | - |
| Profit Margin | - | -216.27 | -537.86 | -117.62 | - | - |
| EBITDA | -51.76 Million | -40.76 Million | - | -50.64 Million | -23.9 Million | -45.74 Million |
| Earnings Before Tax Margin | - | -244.73 | -541.86 | -123.01 | - | - |
TD-PFA
KOG
688110
688659
IR5B
OBRN